Substance use in pregnancy has garnered increasing attention over the
last decade as a particularly concerning facet of the larger national
drug problem. This concern stems from the unique circumstance presente
d by pregnancy, in which the fetus may suffer harm as a result of mate
rnal behavior Furthermore, organizing a response to this problem is co
mplicated by the ethically and legally challenging nature of the mater
nal-fetal relationship. The medical implications of perinatal substanc
e use are profound. A discussion of these associated medical and obste
trical complications lies outside the focus of this paper and the read
er is referred to other reviews (Andres & Jones, 1994; Robins & Mills,
1993). This article is intended to assist obstetricians and others in
their approach to the substance using pregnant patient. We first revi
ew the scope of this problem in social and financial terms and then re
view the important ethical and legal issues involved in current policy
making. Lastly, we suggest a clinical intervention focusing on educati
on and improvement in identification and management of this subset of
patients. (C) 1997 Elsevier Science Inc.